Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation

doi:10.3748/wjg.v13.i5.761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2163)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

412

HTML

1332

Figures (1-6)

240

Tables (1-4)

179

Sum=2163

Feb 7, 2007 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 7, 2007; 13(5): 761-767
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.761

Full Size Figure Download Figure

Figure 1 Survival probabilities for the first 5 yr after treatment. Overall HCC patient survival who had received TACE and OLT, only TACE and patients who received no treatment.

Citation: Obed A, Beham A, Püllmann K, Becker H, Schlitt HJ, Lorf T. Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. World J Gastroenterol 2007; 13(5): 761-767
URL: https://www.wjgnet.com/1007-9327/full/v13/i5/761.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i5.761